Ying Cao (@NeuralGrndState) header
Ying Cao (@NeuralGrndState) profile picture

My rubbish research: the core property of cancer cell is neural stemness, which determines pluripotency&tumorigenicity. EMT/MET/EndMT are groundless 'concepts'

Joined January 2022
Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)Photo by Ying Cao (@NeuralGrndState)
this is what I used to say Because cancers in different organs follow a same rule, a rule that governs both embryogenesis and tumorigenesis frontiersin.org/journals/cel… frontiersin.org/journals/cel… @OncoAlert @DrChoueiri @tompowles1 @apolo_andrea @neerajaiims @montypal @Silke_Gillessen
🧬 Is the tumor microenvironment more conserved than the tumors themselves? Fascinating new study in @Nature! Across 42 cancer types and >2,000 human & mouse tumor samples, Januszyk et al. identify conserved stromal and immune transcriptional programs across organs and species. An exciting step towards understanding shared mechanisms of immune evasion and therapy resistance. Could pan-cancer TME signatures help us develop better biomarkers for immunotherapy—even across different tumor entities? Importantly, shared transcriptional programs ≠ identical therapeutic vulnerabilities. 🔗 doi.org/10.1038/s41586-026-1… Explore the atlas: tmeatlas.stanford.edu @OncoAlert @weoncologists @urotoday @Uromigos @OncoAlert and Faculty: @DrChoueiri @tompowles1 @apolo_andrea @neerajaiims @montypal @Silke_Gillessen @AOmlin @brian_rini @PGrivasMDPhD @TiansterZhang @amerseburger @DrDanielHeng @HHammersMD @scocmem @AndreaNecchi @AmandaNizamMD @drenriquegrande @nataliagandur @AlbigesL @cdanicas @declangmurphy @seanmmcbride @shilpaonc @DrRanaMcKay @scserendipity1 @DrYukselUrun @ravikanesvaran @BraunMDPhD @EfstathiouEleni @mzugman @crisbergerot @Markuseckstein3
1
2
128
this is what I used to say Because tumorigenesis in different organs follows a same rule, a rule that governs both embryogenesis and tumorigenesis frontiersin.org/journals/cel… frontiersin.org/journals/cel… @LungCancerEu
Do cancers in different organs build the same support system? A 🆕 open access study in Nature mapped the cells surrounding tumours across 42 cancer types, using more than 15M human and mouse cells, and found strikingly similar patterns. Authors suggest some of these shared support cells could be targeted with treatments that work across several cancers. Non-small cell #LungCancer was one of the best represented, with 263 of 2,855 human samples. SCLC, which is rarely treated with surgery, contributed 5. Getting tissue for #SCLC research remains a real barrier. nature.com/articles/s41586-0… #SCLC
1
38
this is what I used to say Because tumorigenesis in different organs follows a same rule, a rule that governs both embryogenesis and tumorigenesis frontiersin.org/journals/cel… frontiersin.org/journals/cel…
42がん種、2,000超のヒト・マウス腫瘍の単一細胞データを横断解析し、がんに応答する間質・免疫細胞の転写プログラムに臓器や種を超えて保存された共通特徴があることを示し、TME atlasと解析ツールscTMEを構築した論文がNature誌に発表されました。 nature.com/articles/s41586-0…
1
44
Yes. this is what I used to say. Because tumorigenesis in different organs follows a same rule, a rule that governs both embryogenesis and tumorigenesis. @Nature frontiersin.org/journals/cel… frontiersin.org/journals/cel…
🧬 Is the tumor microenvironment more conserved than the tumors themselves? Fascinating new study in @Nature! Across 42 cancer types and >2,000 human & mouse tumor samples, Januszyk et al. identify conserved stromal and immune transcriptional programs across organs and species. An exciting step towards understanding shared mechanisms of immune evasion and therapy resistance. Could pan-cancer TME signatures help us develop better biomarkers for immunotherapy—even across different tumor entities? Importantly, shared transcriptional programs ≠ identical therapeutic vulnerabilities. 🔗 doi.org/10.1038/s41586-026-1… Explore the atlas: tmeatlas.stanford.edu @OncoAlert @weoncologists @urotoday @Uromigos @OncoAlert and Faculty: @DrChoueiri @tompowles1 @apolo_andrea @neerajaiims @montypal @Silke_Gillessen @AOmlin @brian_rini @PGrivasMDPhD @TiansterZhang @amerseburger @DrDanielHeng @HHammersMD @scocmem @AndreaNecchi @AmandaNizamMD @drenriquegrande @nataliagandur @AlbigesL @cdanicas @declangmurphy @seanmmcbride @shilpaonc @DrRanaMcKay @scserendipity1 @DrYukselUrun @ravikanesvaran @BraunMDPhD @EfstathiouEleni @mzugman @crisbergerot @Markuseckstein3
1
1
61
But seems like that these studies don't exist at all&are not worth mentioning.
5
EGFR, ALK, ROS1, KRAS, BRAF, ...appear as different symbols If you know that all (except 1 or 2) are enriched in embryonic neural cells, then the most essential part of cancer will be better understood 'neural stemness as the core property of cancer cell' frontiersin.org/journals/cel…
🫁 Terapias dirigidas en CPCNP avanzado: nuevas dianas y estrategias. EGFR, ALK, ROS1, KRAS, BRAF, RET, HER2, MET y NTRK, junto con nuevas dianas como NRG1, MTAP y SMARCA4, amplían las opciones terapéuticas. El reto: superar la resistencia adquirida, optimizar las secuencias de tratamiento y garantizar acceso al perfil molecular integral. 📖 @LancetRespirMed @HendriksLizza @dplanchard @MartinReck2 DOI 👉🏻 doi.org/10.1016/S2213-2600(2… #CánCare #LungCancer #NSCLC #PrecisionOncology #ThoracicOncology
35
Basic logic (cell-intrinsic) cancer promoting factors are embryonic neural. they confer cancer cells with neural stemness&pluripotency&tumorigenicity most tumor suppressors are non-neural, eg IgA Understanding cancer by understanding principle of embryonic development. @Nature
1
30
Understanding cancer as a systemic disease through comprehension of neural stemness as the core property of cancer cell and the basic rules it dictates frontiersin.org/journals/cel…
11
cancer cells were the first cells proven to be pluripotency in history (not long ago), which later on inspired the study of ESC pluripotency. but now pluripotency of cancer cells is totally forgotten&AI is worshipped as the hope for understanding cancer cell plasticity...
Can we use #AI to learn the rules of cancer cell plasticity and identify ways to constrain it? My core PhD work on "Decoding the regulatory programs governing glioblastoma plasticity”, is now published in @Nature Explainer from Claude 👇 nature.com/articles/s41586-0…
29
Many reports about intrinsic neural property of cancer cells but not considered in such studies ‘Understanding cancer as a systemic disease through comprehension of neural stemness as the core property of cancer cell and the basic rules it dictates’ frontiersin.org/journals/cel…
19
Critical issue to consider: every study claiming neural signals in tumors are from host nerves should exclude that they are not derived from cancer cells themselves. Seems like that neural property of cancer cells doesn't exist at all&is not worth mentioning @NatureCellBio
1
2
4
180
Understanding cancer as a systemic disease through comprehension of neural stemness as the core property of cancer cell and the basic rules it dictates frontiersin.org/journals/cel…
How far are we from multi-omics states to therapeutic targets in microsatellite-stable colorectal cancer? dlvr.​it/TWKNR5
31
'..oncogenic signaling, immune evasion and epithelial–mesenchymal transition..' What the hell is the magical epithelial-mesenchymal transition? What is clear about it? 'Lack of basic rationale in epithelial-mesenchymal transition and its related concepts’ link.springer.com/article/10…
The prognostic importance of molecular features beyond anatomical staging is becoming increasingly evident in lung cancer. Single-cell molecular analyses provide additional prognostic value beyond staging in predicting recurrence risk, particularly in stage I adenocarcinoma. nature.com/articles/s43018-0…
2
2
95
Conclusion does not only rely on data, but also on basic logic behind
10
Simple logic: E2F1, E2F4, MYC&'EMT core factors' are embryonic neural, SOX17 is non-neural, therefore it represses neural factors incl. the misbegotten 'EMT factors' @naturecancer 'Understanding..neural stemness as the core property of cancer cell&..' frontiersin.org/journals/cel…
18
Immunity plays an important role in cancer, but cancer is not merely a problem of immunity Cancer is the consequence of release of the primitive power hidden in normal cells that determines why animals exist on Earth. frontiersin.org/journals/cel…
You cannot be a great oncologist without a deep understanding of immunology. Cancer is not just a disease of mutated cells. It is also a battle between tumors and the immune system. From checkpoint inhibitors to CAR-T cells, modern oncology is increasingly built on immunology. Yet immunology remains underemphasized in oncology training. It’s time to make advanced immunology a mandatory pillar of oncology education.
27